Hutch News

Hutch News

Stories tagged 'Sunil Hingorani'

Experimental drug makes some pancreatic cancers more vulnerable to chemo

Early trial shows possibility of knocking down a ‘daunting’ cancer’s defense

Dec. 12, 2017 | by Susan Keown / Fred Hutch News Service

An experimental drug that helps chemo penetrate pancreatic tumors lengthened progression-free survival in a Phase 2 trial.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 7, 2017

Fred Hutch Pancreatic cancer researcher Dr. Sunil Hingorani has won a three-year, $1.8 million grant from the federal Cancer Moonshot program, the signature initiative of former Vice President Joseph Biden. Hingorani is one of six collaborators nationwide who received funding this fall for a new research consortium focused on the biological context of pancreatic tumors — such as nearby immune cells or blood vessels — which can have a major impact on a tumor’s vulnerability to treatment.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 29, 2017

Dr. Amanda Paulovich of Fred Hutch has been selected to lead a multi-institution effort to develop a biological test to predict which treatments will work for patients with ovarian cancer.

View story >


Hutch News

Nov. 21, 2016

Stories include: world-renowned oncologist recruited to Fred Hutch, lymphoma patients in remission after experimental immunotherapy and more.

View story >


A new model for pancreatic cancer clinical research

Flexible, precision-medicine trial ‘driven by doing what is best for the individual patient’

Oct. 4, 2016 | By Susan Keown / Fred Hutch News Service

Called “Precision Promise,” this new nationwide precision-medicine trial in pancreatic cancer seeks to turn the concept of clinical trials on its head: Rather than finding participants for a given experimental treatment study, the approach finds the right treatment for a given patient at a given time.

View story >


Pancreatic tumors under pressure

The blood vessel-crushing, chemo-blocking pressure inside pancreatic tumors is almost entirely due to water trapped in gel form, study shows

May 10, 2016 | By Sabrina Richards / Fred Hutch News Service

The blood vessel-crushing, chemo-blocking pressure inside pancreatic tumors is almost entirely due to water trapped in gel form, a new study shows.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.